CryoLife is a brand dedicated to advancing aortic technologies with purpose, focusing on developing simple and elegant solutions to address the challenges faced by cardiac and vascular surgeons when treating patients with aortic diseases. Their breakthrough technologies of unsurpassed quality have a far-reaching impact on surgical outcomes and the lives of patients. With a collaborative approach and partnerships with leading surgeons, CryoLife leverages their combined expertise to create innovative, life-changing aortic-centric technologies.

Their product offerings include a wide range of heart valve solutions, such as the ON-X aortic and mitral heart valves, as well as ascending aortic prostheses and chordal replacement products. In addition to heart valve solutions, CryoLife provides solutions for aortic arch, thoracoabdominal, and peripheral aorta surgery. Their AMDS hybrid prosthesis and E-VITA open neo hybrid stent graft system are designed to treat acute aortic dissections, while their E-NSIDE TAAA multibranch stent graft system offers a solution for thoracoabdominal aortic aneurysms.

At CryoLife, their mission is to empower patients and surgeons with patient-powered progress, offering transformative technologies for aortic diseases